Accelerate your study timeline through our direct-to-patient network

Sanguine has developed a network of 20,000 patients, including 50+ patient advocacy group non-profits, biobanks, and patient portals. Through our direct-to-patient platform, we can dramatically hasten the completion of your study. Download our case studies to learn more about how we can help:

  • How can we accelerate your study timeline? We have an expansive patient network, quick turnaround, and high-touch patient engagement methods.
  • 90+% Recall Rate: Our direct relationships with patients allow us to recontact them for subsequent sampling studies, including clinical trials.
  • Higher Quality Data: We aggregate the patient’s EMR, as well as self-reported information, and most biospecimen samples.

A list of our data and specimen used in 40+ peer-reviewed journal articles:

  • Nature
  • Journal of Immunology
  • Journal of Virology
  • American Society of Microbiology
  • Journal of Biological Chemistry
  • Science

Already have a study in mind? Contact us today at (855) 836-4759 to work together

Download Our Case Studies To Learn More!